4.7 Article

Phosphorylation of ERK and dystrophin S3059 protects against inflammation-associated C2C12 myotube atrophy

期刊

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
卷 320, 期 4, 页码 C956-C965

出版社

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpcell.00513.2020

关键词

dystrophin; ERK; inflammation; muscle atrophy; phosphorylation

资金

  1. National Health and Medical Research Council of Australia (NHMRC) [GNT1041865, GNT1144772]
  2. Early Career Fellowship from the NHMRC
  3. University of Melbourne
  4. NHMRC

向作者/读者索取更多资源

The dystrophin-glycoprotein complex (DGC) is essential for maintaining muscle fiber integrity and transmission of force. Phosphorylation of dystrophin serine 3059 (S3059) plays a role in regulating muscle fiber size and could potentially be targeted for therapeutic interventions against inflammation-associated muscle wasting. Increased ERK activation, dystrophin S3059 phosphorylation, and stable DGC appear to be interconnected in the regulation of muscle fiber size.
The dystrophin-glycoprotein complex (DGC) is a multiprotein structure required to maintain muscle fiber membrane integrity, transmit force by linking the actin cytoskeleton with the extracellular matrix, and maintain muscle homeostasis. Membrane localization of dystrophin is perturbed in muscles wasting as a consequence of cancer cachexia, tenotomy, and advanced aging, which are all associated with low level, chronic inflammation. Strategies to preserve dystrophin expression at the sarcolemma might therefore combat muscle wasting. Phosphorylation of dystrophin serine 3059 (S3059) enhances the interaction between dystrophin and b-dystroglycan. To test the contribution of amino acid phosphorylation to muscle fiber size changes, dystrophin constructs with phospho-null and phosphomimetic mutations were transfected into C2C12 muscle cells or AAV-293 cells in the presence or absence of kinase inhibitors/activators to assess effects on myotube diameter and protein function. Overexpression of a dystrophin construct with a phospho-null mutation at S3059 in vitro reduced myotube size in healthy C2C12 cells. Conversely overexpression of a phosphomimetic mutation at S3059 attenuated inflammation-induced myotube atrophy. Increased ERK activation by addition of phorbol myristate acetate (PMA) also reduced inflammation-associated myotube atrophy and increased the interaction between dystrophin and b-dystroglycan. These findings demonstrate a link between increased ERK activation, dystrophin S3059 phosphorylation, stabilization of the DGC, and the regulation of muscle fiber size. Interventions that increase dystrophin S3059 phosphorylation to promote stronger binding of dystrophin to b-dystroglycan may have therapeutic potential for attenuation of inflammation-associated muscle wasting.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据